What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue? A MASTERMIND study
dc.contributor.author | McGovern, Andrew | |
dc.contributor.author | Dennis, John | |
dc.contributor.author | Shields, Beverley | |
dc.contributor.author | Hattersley, Andrew | |
dc.contributor.author | Pearson, Ewan | |
dc.contributor.author | Jones, Angus | |
dc.date.accessioned | 2023-01-13T16:12:12Z | |
dc.date.available | 2023-01-13T16:12:12Z | |
dc.date.issued | 2019 | en_UK |
dc.identifier.uri | https://rdmc.nottingham.ac.uk/handle/internal/10382 | |
dc.language.iso | en | en_UK |
dc.publisher | Figshare | en_UK |
dc.relation.uri | http://doi.org/10.6084/m9.figshare.c.4470188 | en_UK |
dc.rights | CC-BY | en_UK |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en_UK |
dc.title | What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue? A MASTERMIND study | en_UK |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Research Data Catalogue
A metadata only collection of research data resources, available from or stored at external facilities/repositories